By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Sirtex Medical 

Unit F6, Parkview
16 Mars Road
Lane Cove  New South Wales  2066  Australia
Phone: 61-2-9936-1400 Fax: 61-2-9936-1404


SEARCH JOBS


Industry
Medical Device






Company News
Sirtex Medical (SRX.AX) Release: New Analysis Reveals First-Line Treatment Data On SIR-Spheres Y-90 Resin Microspheres For Patients With Liver Metastases From Right-Sided Primary Colon Cancer 7/5/2017 8:15:51 AM
Sirtex Medical (SRX.AX) Cuts 15% of Workforce in Restructuring 6/28/2017 6:02:22 AM
Sirtex Medical (SRX.AX) Release: SIR-Spheres Y-90 Resin Microspheres Showed No Significant Difference In Overall Survival (OS) Compared To Sorafenib In Advanced HCC With Significantly Fewer Severe Adverse Events, New Asia-Pacific Study Finds 6/6/2017 9:06:41 AM
Sirtex Medical (SRX.AX) Release: Metastatic Colorectal Cancer Patients Treated First-Line With SIR-Spheres Y-90 Resin Microspheres More Likely To Become Candidates For Potentially Curative Liver Surgery, Resect Study Shows 5/24/2017 7:48:43 AM
Sirtex Medical (SRX.AX) Release: SIR-Spheres Y-90 Resin Microspheres Substantially Improves Quality Of Survival In Primary Liver Cancer, New Study Against Standard Treatment Shows 4/24/2017 9:27:14 AM
Sirtex Medical (SRX.AX) Stock Falls on Shareholder Suit 2/3/2017 7:35:35 AM
Sirtex Medical (SRX.AX) Terminates CEO's Contract, Effective Immediately 1/13/2017 5:43:37 AM
Sirtex Medical (SRX.AX) Release: NCCN Guidelines Recommend SIR-Spheres Y-90 Resin Microspheres For The Treatment Of Metastatic Colorectal Cancer 12/12/2016 9:02:37 AM
ReShape Medical Names Former Sirtex Medical (SRX.AX) Exec as New CEO 8/8/2016 6:38:02 AM
Sirtex Medical (SRX.AX) Release: Patients With Colorectal Cancer Liver Metastases Had Significantly Greater Depth Of Tumour Response To SIR-Spheres Y-90 Resin Microspheres, New SIRFLOX Analysis Shows 7/1/2016 6:18:42 AM
12345678
//-->